Mauricio Malavasi Ganança

PubMed2002

Computerized analysis of established craniocorpography.

This study reports 21 patients who suffered from vertigo and underwent a complete otorhinolaryngological evaluation and otoneurological tests to establish a peripheral labyrinthine disorder. All patients were given the Unterberger stepping test in a motion analysis laboratory. Their results were compared to those of a population of 21 normal individuals who were analyzed in the same motion laboratory. A precise description of sway, angular deviation, and test duration was obtained from the VICON motion analysis program. As expected, angular deviation was statistically greater in the group with vestibular disorders.

Adolescent↗

PubMed2002

Clonazepam in the pharmacological treatment of vertigo and tinnitus.

We carried out a retrospective survey of 25 years of clinical experience with the use of clonazepam as a vestibular and tinnitus suppressant in the pharmacological treatment of vestibular or cochleovestibular disorders due to different causes. We reviewed the medical records of 3,357 outpatients treated with a 0.5 or 1.0-mg daily dosage of oral clonazepam during 60-180 days. Complete or substantial control of vertigo or nonvertiginous dizziness was achieved in 77.4% of the vertigo patients. Tinnitus was improved in 32.0% of the tinnitus patients. Light or mild drowsiness, depression, nightmares, or lowering of libido, reported by 16.9% of the patients as adverse side effects, tended to subside with continued therapy. We concluded that clonazepam is a very useful and safe drug for the symptomatic treatment of patients suffering from cochleovestibular disorders.

Adolescent↗